Protagonist Therapeutics, Inc. (PTGX)

105.40 +5.53 (+5.54%) USD  |  NASDAQ  |  Mar 31, 16:00
105.47 +0.07 (+0.07%) After-Hours: 20:00
More

Protagonist Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
AbbVie, Inc. Upgrade
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade